| 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|
| Revenue | 10,0 M € | +39.5% | 7,1 M € | +71.2% | 4,2 M € | |
| EBITDA | -25,6 M € | -28.3% | -20,0 M € | -94.1% | -10,3 M € | |
| Operating profit | -30,0 M € | -35.8% | -22,1 M € | -102.4% | -10,9 M € | |
| Profit/loss | -31,4 M € | -36.5% | -23,0 M € | -101.3% | -11,4 M € | |
| Equity | 4,6 M € | +22.2% | 3,8 M € | +36.3% | 2,8 M € | |
| Total assets | 35,7 M € | +22.3% | 29,2 M € | +40.1% | 20,8 M € | |
| Cash | 2,3 M € | +30.0% | 1,8 M € | +144.9% | 726,8 k € | |
| Debts | 25,5 M € | +3.7% | 24,6 M € | +46.6% | 16,8 M € | |
| Staff | 139,2 | 133,3 | 84 | |||
Public limited company · Charleroi · incorporated on 02/03/2020 · 139,2 ETP
Company — Opening of bankruptcy.
Public limited company loss-making in the latest fiscal year. Cash position rising (+30.0%).
Solid counterparty for a standard engagement.
EXOTHERA is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Charleroi. It employs on average 139,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette